Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 10/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19873543 | 1.00 | LPAR1 (0.38) | LPAR1LPAR3ENPP2LPAR2DGAT1 | |
| SCHEMBL19873630 | 0.91 | LPAR1 (0.42) | LPAR1LPAR3ENPP2LPAR2NPC1 | |
| SCHEMBL19873628 | 0.91 | LPAR1 (0.42) | LPAR1LPAR3ENPP2LPAR2NPC1 | |
| SCHEMBL19873638 | 0.90 | LPAR1 (0.37) | LPAR1LPAR3ENPP2LPAR2DGAT1 | |
| SCHEMBL19873641 | 0.90 | LPAR1 (0.37) | LPAR1LPAR3ENPP2LPAR2DGAT1 | |
| SCHEMBL19873562 | 0.90 | CHRNB2 (0.42) | LPAR1LPAR3ENPP2 | |
| SCHEMBL19873560 | 0.90 | CHRNB2 (0.42) | LPAR1LPAR3ENPP2 | |
| SCHEMBL19873571 | 0.90 | ROCK2 (0.34) | LPAR1LPAR3ENPP2 | |
| SCHEMBL19873573 | 0.90 | ROCK2 (0.34) | LPAR1LPAR3ENPP2 | |
| SCHEMBL19873585 | 0.89 | LPAR1 (0.34) | LPAR1LPAR3ENPP2LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3360869-B1 | HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND USEFUL FOR THE TREATMENT OF DISEASES CAUSED BY LPA. | UBE INDUSTRIES (JP) | 2020-07-29 | — | — | EP | claimed |
| EP-2940013-B1 | HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | UBE INDUSTRIES (JP) | 2018-02-21 | — | — | EP | claimed |